We uncovered the root cause of high drug prices, and you won't believe what's costing Americans💲billions!
We break it down and let you how to help. Check it out: https://t.co/9fPvpQoM8N
@uspto is seeking comments on these proposals through February 1. #drugprices#Medicare
1/x Dr. Jacqueline Corrigan-Curray, Principal Deputy Director of CDER @US_FDA: "Biosimilar competition is driving lower prices among biosimilars and their reference products." #GRxBiosims#biosimilars
Read AAM’s latest white paper, published today, to understand the factors that lead to generic #drugshortages and how best to reduce them.
https://t.co/1SvZfkVyV1
We uncovered the root cause of high drug prices, and you won't believe what's costing Americans💲billions!
We break it down and let you how to help. Check it out: https://t.co/9fPvpQoM8N
@uspto is seeking comments on these proposals through February 1. #drugprices#Medicare
@US_FDA @RepAnnaEshoo @RepGuthrie This bill not only reauthorizes @US_FDA’s user fees to ensure drugs and medical devices are safe and effective. It also:
✅Lowers drug costs
✅Enhances inspections
✅Bolsters clinical trial diversity.
The Food and Drug Amendments bill that passed #SubHealth on Wednesday reauthorizes @US_FDA’s user fees to ensure drugs and medical devices are safe and effective. It also:
✅Lowers drug costs
✅Enhances inspections
✅Bolsters clinical trial diversity
“@FreseniusKabi’s purpose is ‘caring for life’ - to put lifesaving medicines and technologies in the hands of people who care for patients and to find solutions to the challenges they face.” —#AAMBoard member John Ducker. Read more: https://t.co/2HyBcr8EPu